Hernexeos (zongertinib) - Boehringer Ingelheim
Zongertinib in HER2-Mutant Non-Small-Cell Lung Cancer. (PubMed, N Engl J Med) - Sep 10, 2026 - No abstract available 
Journal • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • HER-2
http://www.ncbi.nlm.nih.gov/pubmed/42715577
 
Komal S Pedaballe
 
Sep 10, 2026
 
Prev Next